Aspire Biopharma's Wholly Owned Subsidiary, Buzz Bomb Caffeine Company, to Showcase BUZZ BOMB(TM) Caffeine and its Innovative Sublingual Delivery Technology at The Sports & Active Nutrition Summit

February 5, 2026 8:00 AM

Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), wholly owned subsidiary, Buzz Bomb Caffeine Company, a marketer of a proprietary sublingual caffeine supplement today announced its participation at The Sports & Active Nutrition Summit USA, scheduled for February 18-20 in San Diego, CA. Aspire will feature its flagship caffeine product, BUZZ BOMB™, at the event.The Sports & Active Nutrition Summit USA is a premier...

Read more

Zomedica Announces "Fourth Friday at Four" Webinar on February 27th Focused on Research & Development and Its Innovation Pipeline

February 5, 2026 6:30 AM

Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), an animal health company offering innovative diagnostic and therapeutic devices for equine and companion animals, today announced the next installment of its "Fourth Friday at Four" investor webinar series, scheduled for Friday, February 27, 2026 at 4:00 p.m. Eastern Time.The February program, titled "Inside Innovation: Advancing Animal Health Through Research & Development," will...

Read more

BioNxt Secures Innovative Chaperone Technology to Enhance Oral Thin-Film Drug Delivery

February 5, 2026 3:05 AM

BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems, today announced the signing of a non-binding letter of intent ("LOI") outlining a proposed transaction pursuant to which BioNxt would secure exclusive rights to advanced drug chaperone technology for oral dissolvable applications from a third-party biotechnology developer focused on...

Read more

Bio-Xin Cosmeceuticals Announces Expansion of Personalized Skincare Solutions Globally

February 5, 2026 3:00 AM

Bio-Xin Cosmeceuticals, led by Founder & CEO Muhammad Zahidul Hoque, is set to expand its personalized skincare solutions globally, revolutionizing the industry through science and empowerment.Revolutionizing Aesthetic Care with Personalized SolutionsBio-Xin Cosmeceuticals, a leading force in the global skincare and wellness industry, is taking a significant step forward in its mission to revolutionize the skincare experience. The company,...

Read more

MEDvidi Announces AI Clinical Assistant to Address the Shortage of Mental Health Professionals

February 5, 2026 2:55 AM

The mental health sector is poised for transformation. More than 32 million Americans face barriers to treatment, and the national shortage of mental health professionals is projected to exceed 20,000 by 2030. Today, with over 65% of clinicians' time being consumed by administrative work and routine follow-up visits, the current healthcare delivery model becomes unsustainable. MEDvidi's AI systems are built to change that. Instead of...

Read more

Pentixapharm Announces Peer-Reviewed Phase 2 Data Back Use of PENTIXAFOR as a Superior Non-invasive PET-Diagnostic for Primary Aldosteronism

February 5, 2026 2:50 AM

Pentixapharm Holding AG (Frankfurt Prime Standard:PTP), an advanced clinical-stage biotech developing novel radiopharmaceuticals, today announced publication of new Phase 2 clinical data in the Journal of Nuclear Medicine demonstrating the potential of [68Ga]Ga-Pentixafor PET/CT as a non-invasive imaging tool for subtyping primary aldosteronism (PA), the leading endocrine cause of hypertension.The investigator-initiated study, funded by an...

Read more

Spago Nanomedical Year-End Report January-December, 2025

February 5, 2026 2:20 AM

Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F)OCTOBER - DECEMBER IN BRIEFNet sales for the quarter amounted to KSEK 4 (KSEK 617)The loss for the quarter amounted to KSEK -5,890 (KSEK -7,830)Operating expenses for the quarter amounted to KSEK -6,943 (KSEK -10,223)Earnings per share, before and after dilution, for the quarter amounted to SEK -0.01 (SEK -0. 02)JANUARY - DECEMBER IN BRIEFNet sales for the year amounted to KSEK 437 (KSEK 1,911)The loss...

Read more

Full Year and Q4 Report 2025: FDA Accepts Orviglance NDA for Review

February 5, 2026 1:50 AM

Ascelia Pharma AB (publ) (ticker:ACE)(STO:ACE) today published its Full Year and Q4 Report for 2025 (January - December), which is now available on the company's website: Financial Reports - ASCELIAKEY EVENTS IN Q4 2025FDA accepts Orviglance® NDA for review aiming for a decision by 3 July 2026 as the PDUFA dateFiling of a new patent application for OrviglanceManagement changes to support future growthConversion of series C shares into ordinary...

Read more

Life Imaging FLA Reviews the Biggest Questions in Preventive Screening for 2026

February 4, 2026 7:05 PM

Life Imaging FLA today announced a new 2026 initiative that will systematically review the biggest questions in preventive screening and early detection, with a focus on heart disease and cancer.The company, which provides preventive heart and full body screening for adults over 20, will use this internal review to strengthen how it educates the public, supports clinicians, and designs its own services."Every year, we see how much difference it...

Read more

Onco-Innovations Announces Filing of Preliminary Base Shelf Prospectus

February 4, 2026 6:00 PM

Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN:A3EKSZ) ("Onco" or the "Company") announces that it has filed a preliminary base shelf prospectus dated February 3, 2026 (the "Base Shelf Prospectus") with the securities regulatory authorities in each of the provinces of Alberta, British Columbia, Manitoba and Ontario. The Base Shelf Prospectus has been filed, but is not yet final, and the securities described therein may...

Read more

URLuminous Marks World Cancer Day By Advancing Awareness-First Breast Health With Luminous Pro Series And Companion App

February 4, 2026 2:50 PM

In recognition of World Cancer Day, URLuminous is spotlighting its mission to transform breast health through awareness-first technology with the Luminous Pro Series and the Luminous Breast App - tools designed to help individuals and physicians build familiarity with breast health and encourage earlier medical follow-up when changes are detected. The Luminous Pro Series is currently used in various international markets and has received...

Read more

John H. Weston Jr. Launches a Personal Pledge to Reduce Preventable Behavioral Crises in Community Care

February 4, 2026 11:03 AM

John H. Weston Jr., operator and leader of Capitol City Residential Health Care, today announced the launch of a personal pledge focused on reducing preventable behavioral crises in community-based residential settings. The pledge formalizes a set of concrete behaviors Weston has committed to in response to rising acuity, staffing pressure, and avoidable emergency interventions across the sector.The pledge is grounded in operational realities...

Read more

Utah Medical Products, Inc. Announces Quarterly Dividend

February 4, 2026 10:00 AM

Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty-one cents ($.31) per share of common stock payable on April 3, 2026 to stockholders of record at the close of business on March 17, 2026. This is a 1.6% increase over the dividend declared in the same quarter of the prior year.Utah Medical Products, Inc., with particular interest in health care for women and their babies,...

Read more

AGFA HealthCare Named Best in KLAS(R) 2026 Across Three Enterprise Imaging Segments in the United States

February 4, 2026 9:45 AM

AGFA HealthCare today announced that it has been named Best in KLAS® 2026 across three Enterprise Imaging segments in the United States, with two awards earned for the second consecutive year, underscoring the company's continued leadership in delivering clinician-first imaging solutions trusted by healthcare organizations worldwide.The recognition comes as KLAS Research marks its 30th anniversary, celebrating three decades of amplifying the...

Read more

Revecore Earns Sixth Consecutive Best in KLAS Award for Complex Claims Services

February 4, 2026 9:03 AM

Revecore, a leading provider of complex revenue cycle management solutions for hospital systems nationwide, today announced it has earned its sixth consecutive Best in KLAS award for Complex Claims Services in the 2026 Best in KLAS: Software & Services Report. With this distinction, Revecore builds on the record it established in 2025 for the most consecutive Best in KLAS wins in the Complex Claims category.The Best in KLAS awards are based on...

Read more

CenExel Completes Metabolic Task Force Training Across Site Network

February 4, 2026 9:00 AM

CenExel, a leading, wholly owned clinical research site network, recently completed its comprehensive Metabolic Task Force training, one of three Task Forces designed to advance a unified approach to patient-focused care.The training is a direct response to the highly evolving pace of metabolic research, such as GLP-1s, and the growing need to navigate the complexities of emerging metabolic clinical trials. Ensuring clinical sites are equipped...

Read more

EDGE Surgical to Showcase Rapid Growth and Global Expansion at AAOS 2026

February 4, 2026 9:00 AM

EDGE Surgical, Inc., the pioneering force behind the world's only electronic depth gauge for orthopedic surgery, is thrilled to announce its participation as an exhibitor at the 2026 American Academy of Orthopedic Surgeons (AAOS) Annual Meeting, taking place from March 2-6 at the Morial Convention Center in New Orleans, Louisiana. EDGE will highlight accelerating commercial growth, expanding surgeon adoption, and continued progress toward global...

Read more

GridAI Technologies Corp. Appoints Veteran Energy Executive Tim Healy as Executive Chairman of Grid AI Corp.

February 4, 2026 8:45 AM

GridAI Technologies Corp. (Nasdaq:GRDX), a technology company focused on intelligent energy orchestration for hyperscale AI data centers, today announced the appointment of Tim Healy as Executive Chairman of the Board of Grid AI Corp., the Company's wholly owned operating subsidiary.Healy brings more than two decades of experience as a founder, CEO, board leader, and investor across the energy technology and energy transition landscape. Over his...

Read more

Modular Medical Achieves Key Manufacturing Milestone for Pivot Tubeless Insulin Patch Pump

February 4, 2026 8:30 AM

Modular Medical, Inc. ("Modular Medical" or the "Company") (NASDAQ:MODD), an innovative insulin delivery technology company, today announced the start of production of validation lots for its Pivot™ tubeless patch pump's disposable cartridge and infusion set. Achievement of this critical manufacturing milestone keeps the Company on schedule for commercial launch in Q1 2026, subject to receipt of FDA 510(k) clearance.The Pivot system - the...

Read more

Indonesia Hospitals Step Up EHR Modernization; Momentum Grows for Core System Replacement Within 24 Months, New Black Book Report Finds

February 4, 2026 7:30 AM

Black Book Market Research LLC today announced the release of "State of Digital Healthcare Technology: Indonesia 2026," a new market report examining how the nation's hospitals are modernizing SIMRS/HIS and EHR platforms as compliance requirements and interoperability expectations reshape technology roadmaps. The report finds Indonesia's acute care provider market moving rapidly from foundational digitization to modernization at scale, driven...

Read more